Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2003
11/12/2003EP1360331A2 Vector system used in screening active substances
11/12/2003EP1360327A1 Method for identifying genes regulating desired cell phenotypes
11/12/2003EP1360326A2 Cell based triple readout assay systems for identifying compounds that affect transcription
11/12/2003EP1360325A2 Multiplex quantification of nucleic acids in diseased cells
11/12/2003EP1360322A2 Detection of microsatellite instability and its use in diagnosis of tumors
11/12/2003EP1360319A2 Diagnosis of diseases associated with metabolism
11/12/2003EP1360318A2 Method of detection by enhancement of silver staining
11/12/2003EP1360317A2 Detection of aberrant dna methylation as marker for human cancer
11/12/2003EP1360313A2 Carotenoid biosynthesis
11/12/2003EP1360312A1 Method for l-threonine production
11/12/2003EP1360311A2 Membrane penetrating peptides and uses thereof
11/12/2003EP1360310A2 A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes
11/12/2003EP1360309A2 Nucleic acid sequences to proteins involved in tocopherol synthesis
11/12/2003EP1360308A2 Concatemers of differentially expressed multiple genes
11/12/2003EP1360307A2 Chimeric polypeptides of serum albumin and uses related thereto
11/12/2003EP1360306A2 Dna sequence of the enzyme phospholipase a1 of ciliate tetrahymena, and the use of the same
11/12/2003EP1360305A2 A process for the fermentative preparation of d-pantothenic acid and/or its salts
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360303A2 Process for the fermentative production of d-pantothenic acid
11/12/2003EP1360302A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/12/2003EP1360301A2 Genes involved in isoprenoid compound production
11/12/2003EP1360300A2 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
11/12/2003EP1360299A2 The genome of a bifidobacterium
11/12/2003EP1360298A2 Nucleotide sequences of the ribosomal protein s12 gene (rpsl) from corynebacterium glutamicum
11/12/2003EP1360297A2 Ragweed allergens
11/12/2003EP1360296A2 Method for the production of plant seed with modified fibre content and modified seed coat
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360294A2 Regulation of human dorsal root receptor-like g protein-coupled receptor
11/12/2003EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
11/12/2003EP1360292A2 Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof
11/12/2003EP1360291A2 Human polynucleotides and polypeptides encoded thereby
11/12/2003EP1360290A2 Co-stimulatory molecules
11/12/2003EP1360289A1 Method of eukaryotic expression cloning of disease associated molecules
11/12/2003EP1360288A2 Focused libraries of genetic packages
11/12/2003EP1360287A1 Methods of modifying eukaryotic cells
11/12/2003EP1360286A2 Characterization of the gsk-3beta protein and methods of use thereof
11/12/2003EP1360284A2 Recombinant proteinase k
11/12/2003EP1360283A2 Expression of recombinant proteinase k from i tritirachium album /i in yeast
11/12/2003EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility
11/12/2003EP1360278A2 Lipase variants
11/12/2003EP1360277A2 Multipotent o-2a progenitors from the neurohypophysis
11/12/2003EP1360276A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses
11/12/2003EP1360206A2 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof
11/12/2003EP1360205A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/12/2003EP1360204A2 Test system for the development of therapeutic agents, in particular active compounds for the treatment of osteoporosis
11/12/2003EP1360199A2 Treatment involving dkk-1 or antagonists thereof
11/12/2003EP1360198A2 Novel polypeptides and nucleic acids encoded thereby
11/12/2003EP1360197A2 Histidine phosphatase interacting protein with 240kd
11/12/2003EP1360196A2 Improved method for production of secreted proteins in fungi
11/12/2003EP1360195A2 H. influenzae antigen basb213
11/12/2003EP1360194A2 Systems for expression of heterologous proteins in m. capsulatus
11/12/2003EP1360193A1 Method for purifying the helicobacter adhesin-like protein a (alpa)
11/12/2003EP1360191A2 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo
11/12/2003EP1359938A2 Method for treating psoriasis by using an il-17d antagonist
11/12/2003EP1359937A1 Altered peptide ligands
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP1359797A1 Human sphingosine-1-phosphate phosphatase
11/12/2003EP1196637A4 Peptide acceptor ligation methods
11/12/2003EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies
11/12/2003EP1084257B1 A STRAIN E.COLI JM83/pKP2 TRANSFORMED WITH A NOVEL PLASMID AND PHYTASE PRODUCED THEREFROM
11/12/2003EP1077830B1 Vehicle seat assembly with thermoformed fibrous suspension panel
11/12/2003EP1007624B1 Ds11 (kctc 0231bp), novel bacillus sp. strain and novel phytase produced by it
11/12/2003EP0994904B1 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
11/12/2003EP0938574B1 Method for inducing viral resistance into a plant
11/12/2003EP0897390B1 Human tumor necrosis factor delta and epsilon
11/12/2003EP0847272B1 LIPOSOMAL p-ETHOXY OLIGONUCLEOTIDES
11/12/2003EP0840742A4 Systematic evolution of ligands by exponential enrichment: chemi-selex
11/12/2003EP0775203B1 Method of gene therapy using dna vectors without selection marker gene
11/12/2003EP0773952B1 Interaction trap systems for detecting protein interactions
11/12/2003EP0767837B1 Increased production of beta-galactosidase in aspergillus oryzae
11/12/2003EP0759759B1 P75 tnf receptor promoters
11/12/2003EP0742829B1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/12/2003EP0741515B1 Transgenic production of antibodies in milk
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455817A Methods for replacement, translocation and stacking of DNA in eukaryotic genomes
11/12/2003CN1455816A Rescue of canine distemper virus from CDNA
11/12/2003CN1455815A Malaria plasmodium antigen polypeptide SE36, method of purifying same and vaccine and diagnosis with use of obtained antigen
11/12/2003CN1455814A Polynucleotide probe and primer originating in hepatitis E virus of Japanese, chips having the same, kits having the same and method for detecting thereof
11/12/2003CN1455813A Human myeloma cell line
11/12/2003CN1455682A Compositions for gene therapy of rheumatoid arthritis including gene encoding anti-angiogenic protein or parts thereof
11/12/2003CN1455680A MUCl extracellular domain and cancer treatment compositions and methods derived therefrom
11/12/2003CN1455674A Use of sheep's parapoxvirus bacterial strain for preparing anti-virus medicines and anti-cancer medicine
11/12/2003CN1455668A Gene conferring resistance to antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same and applications thereof
11/12/2003CN1455001A Exendin-4 polypeptide preparation method
11/12/2003CN1454998A Method of conducting plant seed transgene using transverse alternating pulse electrophoresis
11/12/2003CN1454997A Rape sodium-hydrogen pump transport protein coding sequence and application thereof
11/12/2003CN1454996A Screening non-infective virus recombinant gene SARS-Cov-EGFP for medicine of anti SARS coronavirus
11/12/2003CN1454991A Method of increasing super rice yield applying transgene technique
11/12/2003CN1454989A Yeast genetically engineered strain expressing hrp gene and constructing method thereof
11/12/2003CN1454988A Humicole uspergillus
11/12/2003CN1454900A Glucose and insulin response element
11/12/2003CN1127571C Permentative production of valuable compounds on industrial scale using chemically defined media
11/12/2003CN1127570C Use of castor silkworm cell nucleus and skeleton combination elements
11/12/2003CN1127569C Method for mass production of antimicrobial peptide
11/12/2003CN1127568C Fibroblast growth factor homologs
11/12/2003CN1127517C Trophic fuctors for central nervous system
11/12/2003CN1127516C Novel polypeptides
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/12/2003CN1127343C Myoblast therapy for mammalian diseases
11/11/2003USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex